SpecGx, LLC recalls Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119,
Recalled January 14, 2026 · FDA recall D-0255-2026 · SpecGx
Hazard
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets. · FDA Class II
Units
74,544 bottles
Sold at
Nationwide
Description
Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Product
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
Manufacturer(s)
SpecGx, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →